rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Amy Simon

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Beam Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
30
Buys
0
Sells
15
Bought
$0
Sold
$3.1M
Companies
1
Companies where not an officer
0
First trade
31 Mar 2023
Last trade
27 Jul 2026
Last filed
29 Jul 2026

Companies traded

Where they are an officer
BEAM Beam TherapeuticsOfficer · Genomics & Gene Editing · last 27 Jul 20260 buys · 15 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Jul 2026filed 29 Jul 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$429K16,667 at $25.74filing
27 Jul 2026filed 29 Jul 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$429K16,667 at $25.74filing
30 Jun 2026filed 2 Jul 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$13K373 at $34.73filing
30 Jun 2026filed 2 Jul 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$13K373 at $34.73filing
1 Apr 2026filed 6 Apr 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$165K6,700 at $24.58filing
1 Apr 2026filed 6 Apr 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$165K6,700 at $24.58filing
31 Mar 2026filed 2 Apr 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Code A—31,750 at $0.00filing
31 Mar 2026filed 2 Apr 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Code A—31,750 at $0.00filing
31 Jan 2026filed 2 Feb 2026BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—88,500 at $0.00filing
31 Jan 2026filed 2 Feb 2026BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—88,500 at $0.00filing
31 Dec 2025filed 5 Jan 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Code A—12,500 at $0.00filing
31 Dec 2025filed 5 Jan 2026BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Code A—12,500 at $0.00filing
3 Jul 2025filed 3 Jul 2025BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$18K876 at $20.12filing
1 Jul 2025filed 3 Jul 2025BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$6,336374 at $16.94filing
2 Apr 2025filed 3 Apr 2025BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$372K20,997 at $17.73filing
1 Apr 2025filed 3 Apr 2025BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$176K9,566 at $18.35filing
31 Mar 2025filed 2 Apr 2025BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Code A—27,500 at $0.00filing
31 Jan 2025filed 3 Feb 2025BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—55,000 at $0.00filing
2 Jul 2024filed 3 Jul 2024BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$17K748 at $22.95filing
1 Jul 2024filed 3 Jul 2024BEAM Beam TherapeuticsGenomics & Gene EditingSEC FORM 4 Sold$12K502 at $23.76filing

Sectors

Health Care15

Buys in green, sells in red, by the company’s sector.

Related people

John M. EvansCEO · CEO at Beam Therapeutics, filing Form 4 there in the last year
Bethany J. CavanaghSVP, Finance and Treasurer · SVP, Finance and Treasurer at Beam Therapeutics, filing Form 4 there in the last year
Giuseppe CiaramellaPresident · President at Beam Therapeutics, filing Form 4 there in the last year
FMR LLC10% owner and Other role · 10% owner and Other at Beam Therapeutics, filing Form 4 there in the last year
John MaraganoreDirector · Director at Beam Therapeutics, filing Form 4 there in the last year